Pharma & Healthcare
Global Pain Reliever Market Research Report 2026
- Nov 14, 26
- ID: 765159
- Pages: 121
- Figures: 119
- Views: 4
The global Pain Reliever market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Pain Reliever competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report delivers a comprehensive overview of the global Pain Reliever market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Pain Reliever. The Pain Reliever market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Pain Reliever market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Pain Reliever manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Pfizer
GSK
Grunenthal
Bayer
Sanofi
Eli Lilly
AstraZeneca
Endo
Merck
Depomed
Yunnan Baiyao
Teva
J&J
Allergan
Purdue
Segment by Type
Generic Opioids
Branded Opioids
NSAIDs
Others
by Application
Hospitals
Clinics
Drugstores
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Pain Reliever manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Pain Reliever sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Pain Reliever competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report delivers a comprehensive overview of the global Pain Reliever market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Pain Reliever. The Pain Reliever market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Pain Reliever market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Pain Reliever manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Pfizer
GSK
Grunenthal
Bayer
Sanofi
Eli Lilly
AstraZeneca
Endo
Merck
Depomed
Yunnan Baiyao
Teva
J&J
Allergan
Purdue
Segment by Type
Generic Opioids
Branded Opioids
NSAIDs
Others
by Application
Hospitals
Clinics
Drugstores
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Pain Reliever manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Pain Reliever sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
1 Pain Reliever Market Overview
1.1 Product Definition
1.2 Pain Reliever by Type
1.2.1 Global Pain Reliever Market Value by Type: 2025 vs 2032
1.2.2 Generic Opioids
1.2.3 Branded Opioids
1.2.4 NSAIDs
1.2.5 Others
1.3 Pain Reliever by Application
1.3.1 Global Pain Reliever Market Value by Application: 2025 vs 2032
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Drugstores
1.4 Global Pain Reliever Market Size Estimates and Forecasts
1.4.1 Global Pain Reliever Revenue 2021–2032
1.4.2 Global Pain Reliever Sales 2021–2032
1.4.3 Global Pain Reliever Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Pain Reliever Market Competition by Manufacturers
2.1 Global Pain Reliever Sales Market Share by Manufacturers (2021–2026)
2.2 Global Pain Reliever Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Pain Reliever Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Pain Reliever, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Pain Reliever, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Pain Reliever, Product Types and Applications
2.7 Global Key Manufacturers of Pain Reliever, Date of Entry into the Industry
2.8 Global Pain Reliever Market Competitive Situation and Trends
2.8.1 Global Pain Reliever Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Pain Reliever Players Market Share by Revenue
2.8.3 Global Pain Reliever Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Pain Reliever Market Scenario by Region
3.1 Global Pain Reliever Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Pain Reliever Sales by Region: 2021–2032
3.2.1 Global Pain Reliever Sales by Region: 2021–2026
3.2.2 Global Pain Reliever Sales by Region: 2027–2032
3.3 Global Pain Reliever Revenue by Region: 2021–2032
3.3.1 Global Pain Reliever Revenue by Region: 2021–2026
3.3.2 Global Pain Reliever Revenue by Region: 2027–2032
3.4 North America Pain Reliever Market Facts & Figures by Country
3.4.1 North America Pain Reliever Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Pain Reliever Sales by Country (2021–2032)
3.4.3 North America Pain Reliever Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Pain Reliever Market Facts & Figures by Country
3.5.1 Europe Pain Reliever Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Pain Reliever Sales by Country (2021–2032)
3.5.3 Europe Pain Reliever Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Pain Reliever Market Facts & Figures by Region
3.6.1 Asia Pacific Pain Reliever Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Pain Reliever Sales by Region (2021–2032)
3.6.3 Asia Pacific Pain Reliever Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Pain Reliever Market Facts & Figures by Country
3.7.1 Latin America Pain Reliever Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Pain Reliever Sales by Country (2021–2032)
3.7.3 Latin America Pain Reliever Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Pain Reliever Market Facts & Figures by Country
3.8.1 Middle East and Africa Pain Reliever Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Pain Reliever Sales by Country (2021–2032)
3.8.3 Middle East and Africa Pain Reliever Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Pain Reliever Sales by Type (2021–2032)
4.1.1 Global Pain Reliever Sales by Type (2021–2026)
4.1.2 Global Pain Reliever Sales by Type (2027–2032)
4.1.3 Global Pain Reliever Sales Market Share by Type (2021–2032)
4.2 Global Pain Reliever Revenue by Type (2021–2032)
4.2.1 Global Pain Reliever Revenue by Type (2021–2026)
4.2.2 Global Pain Reliever Revenue by Type (2027–2032)
4.2.3 Global Pain Reliever Revenue Market Share by Type (2021–2032)
4.3 Global Pain Reliever Price by Type (2021–2032)
5 Segment by Application
5.1 Global Pain Reliever Sales by Application (2021–2032)
5.1.1 Global Pain Reliever Sales by Application (2021–2026)
5.1.2 Global Pain Reliever Sales by Application (2027–2032)
5.1.3 Global Pain Reliever Sales Market Share by Application (2021–2032)
5.2 Global Pain Reliever Revenue by Application (2021–2032)
5.2.1 Global Pain Reliever Revenue by Application (2021–2026)
5.2.2 Global Pain Reliever Revenue by Application (2027–2032)
5.2.3 Global Pain Reliever Revenue Market Share by Application (2021–2032)
5.3 Global Pain Reliever Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Company Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Pain Reliever Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Pfizer Pain Reliever Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 GSK
6.2.1 GSK Company Information
6.2.2 GSK Description and Business Overview
6.2.3 GSK Pain Reliever Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 GSK Pain Reliever Product Portfolio
6.2.5 GSK Recent Developments/Updates
6.3 Grunenthal
6.3.1 Grunenthal Company Information
6.3.2 Grunenthal Description and Business Overview
6.3.3 Grunenthal Pain Reliever Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Grunenthal Pain Reliever Product Portfolio
6.3.5 Grunenthal Recent Developments/Updates
6.4 Bayer
6.4.1 Bayer Company Information
6.4.2 Bayer Description and Business Overview
6.4.3 Bayer Pain Reliever Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Bayer Pain Reliever Product Portfolio
6.4.5 Bayer Recent Developments/Updates
6.5 Sanofi
6.5.1 Sanofi Company Information
6.5.2 Sanofi Description and Business Overview
6.5.3 Sanofi Pain Reliever Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Sanofi Pain Reliever Product Portfolio
6.5.5 Sanofi Recent Developments/Updates
6.6 Eli Lilly
6.6.1 Eli Lilly Company Information
6.6.2 Eli Lilly Description and Business Overview
6.6.3 Eli Lilly Pain Reliever Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Eli Lilly Pain Reliever Product Portfolio
6.6.5 Eli Lilly Recent Developments/Updates
6.7 AstraZeneca
6.7.1 AstraZeneca Company Information
6.7.2 AstraZeneca Description and Business Overview
6.7.3 AstraZeneca Pain Reliever Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 AstraZeneca Pain Reliever Product Portfolio
6.7.5 AstraZeneca Recent Developments/Updates
6.8 Endo
6.8.1 Endo Company Information
6.8.2 Endo Description and Business Overview
6.8.3 Endo Pain Reliever Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Endo Pain Reliever Product Portfolio
6.8.5 Endo Recent Developments/Updates
6.9 Merck
6.9.1 Merck Company Information
6.9.2 Merck Description and Business Overview
6.9.3 Merck Pain Reliever Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Merck Pain Reliever Product Portfolio
6.9.5 Merck Recent Developments/Updates
6.10 Depomed
6.10.1 Depomed Company Information
6.10.2 Depomed Description and Business Overview
6.10.3 Depomed Pain Reliever Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Depomed Pain Reliever Product Portfolio
6.10.5 Depomed Recent Developments/Updates
6.11 Yunnan Baiyao
6.11.1 Yunnan Baiyao Company Information
6.11.2 Yunnan Baiyao Description and Business Overview
6.11.3 Yunnan Baiyao Pain Reliever Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Yunnan Baiyao Pain Reliever Product Portfolio
6.11.5 Yunnan Baiyao Recent Developments/Updates
6.12 Teva
6.12.1 Teva Company Information
6.12.2 Teva Description and Business Overview
6.12.3 Teva Pain Reliever Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Teva Pain Reliever Product Portfolio
6.12.5 Teva Recent Developments/Updates
6.13 J&J
6.13.1 J&J Company Information
6.13.2 J&J Description and Business Overview
6.13.3 J&J Pain Reliever Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 J&J Pain Reliever Product Portfolio
6.13.5 J&J Recent Developments/Updates
6.14 Allergan
6.14.1 Allergan Company Information
6.14.2 Allergan Description and Business Overview
6.14.3 Allergan Pain Reliever Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 Allergan Pain Reliever Product Portfolio
6.14.5 Allergan Recent Developments/Updates
6.15 Purdue
6.15.1 Purdue Company Information
6.15.2 Purdue Description and Business Overview
6.15.3 Purdue Pain Reliever Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 Purdue Pain Reliever Product Portfolio
6.15.5 Purdue Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Pain Reliever Industry Chain Analysis
7.2 Pain Reliever Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Pain Reliever Production Mode & Process Analysis
7.4 Pain Reliever Sales and Marketing
7.4.1 Pain Reliever Sales Channels
7.4.2 Pain Reliever Distributors
7.5 Pain Reliever Customer Analysis
8 Pain Reliever Market Dynamics
8.1 Pain Reliever Industry Trends
8.2 Pain Reliever Market Drivers
8.3 Pain Reliever Market Challenges
8.4 Pain Reliever Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Pain Reliever by Type
1.2.1 Global Pain Reliever Market Value by Type: 2025 vs 2032
1.2.2 Generic Opioids
1.2.3 Branded Opioids
1.2.4 NSAIDs
1.2.5 Others
1.3 Pain Reliever by Application
1.3.1 Global Pain Reliever Market Value by Application: 2025 vs 2032
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Drugstores
1.4 Global Pain Reliever Market Size Estimates and Forecasts
1.4.1 Global Pain Reliever Revenue 2021–2032
1.4.2 Global Pain Reliever Sales 2021–2032
1.4.3 Global Pain Reliever Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Pain Reliever Market Competition by Manufacturers
2.1 Global Pain Reliever Sales Market Share by Manufacturers (2021–2026)
2.2 Global Pain Reliever Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Pain Reliever Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Pain Reliever, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Pain Reliever, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Pain Reliever, Product Types and Applications
2.7 Global Key Manufacturers of Pain Reliever, Date of Entry into the Industry
2.8 Global Pain Reliever Market Competitive Situation and Trends
2.8.1 Global Pain Reliever Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Pain Reliever Players Market Share by Revenue
2.8.3 Global Pain Reliever Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Pain Reliever Market Scenario by Region
3.1 Global Pain Reliever Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Pain Reliever Sales by Region: 2021–2032
3.2.1 Global Pain Reliever Sales by Region: 2021–2026
3.2.2 Global Pain Reliever Sales by Region: 2027–2032
3.3 Global Pain Reliever Revenue by Region: 2021–2032
3.3.1 Global Pain Reliever Revenue by Region: 2021–2026
3.3.2 Global Pain Reliever Revenue by Region: 2027–2032
3.4 North America Pain Reliever Market Facts & Figures by Country
3.4.1 North America Pain Reliever Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Pain Reliever Sales by Country (2021–2032)
3.4.3 North America Pain Reliever Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Pain Reliever Market Facts & Figures by Country
3.5.1 Europe Pain Reliever Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Pain Reliever Sales by Country (2021–2032)
3.5.3 Europe Pain Reliever Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Pain Reliever Market Facts & Figures by Region
3.6.1 Asia Pacific Pain Reliever Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Pain Reliever Sales by Region (2021–2032)
3.6.3 Asia Pacific Pain Reliever Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Pain Reliever Market Facts & Figures by Country
3.7.1 Latin America Pain Reliever Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Pain Reliever Sales by Country (2021–2032)
3.7.3 Latin America Pain Reliever Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Pain Reliever Market Facts & Figures by Country
3.8.1 Middle East and Africa Pain Reliever Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Pain Reliever Sales by Country (2021–2032)
3.8.3 Middle East and Africa Pain Reliever Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Pain Reliever Sales by Type (2021–2032)
4.1.1 Global Pain Reliever Sales by Type (2021–2026)
4.1.2 Global Pain Reliever Sales by Type (2027–2032)
4.1.3 Global Pain Reliever Sales Market Share by Type (2021–2032)
4.2 Global Pain Reliever Revenue by Type (2021–2032)
4.2.1 Global Pain Reliever Revenue by Type (2021–2026)
4.2.2 Global Pain Reliever Revenue by Type (2027–2032)
4.2.3 Global Pain Reliever Revenue Market Share by Type (2021–2032)
4.3 Global Pain Reliever Price by Type (2021–2032)
5 Segment by Application
5.1 Global Pain Reliever Sales by Application (2021–2032)
5.1.1 Global Pain Reliever Sales by Application (2021–2026)
5.1.2 Global Pain Reliever Sales by Application (2027–2032)
5.1.3 Global Pain Reliever Sales Market Share by Application (2021–2032)
5.2 Global Pain Reliever Revenue by Application (2021–2032)
5.2.1 Global Pain Reliever Revenue by Application (2021–2026)
5.2.2 Global Pain Reliever Revenue by Application (2027–2032)
5.2.3 Global Pain Reliever Revenue Market Share by Application (2021–2032)
5.3 Global Pain Reliever Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Company Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Pain Reliever Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Pfizer Pain Reliever Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 GSK
6.2.1 GSK Company Information
6.2.2 GSK Description and Business Overview
6.2.3 GSK Pain Reliever Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 GSK Pain Reliever Product Portfolio
6.2.5 GSK Recent Developments/Updates
6.3 Grunenthal
6.3.1 Grunenthal Company Information
6.3.2 Grunenthal Description and Business Overview
6.3.3 Grunenthal Pain Reliever Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Grunenthal Pain Reliever Product Portfolio
6.3.5 Grunenthal Recent Developments/Updates
6.4 Bayer
6.4.1 Bayer Company Information
6.4.2 Bayer Description and Business Overview
6.4.3 Bayer Pain Reliever Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Bayer Pain Reliever Product Portfolio
6.4.5 Bayer Recent Developments/Updates
6.5 Sanofi
6.5.1 Sanofi Company Information
6.5.2 Sanofi Description and Business Overview
6.5.3 Sanofi Pain Reliever Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Sanofi Pain Reliever Product Portfolio
6.5.5 Sanofi Recent Developments/Updates
6.6 Eli Lilly
6.6.1 Eli Lilly Company Information
6.6.2 Eli Lilly Description and Business Overview
6.6.3 Eli Lilly Pain Reliever Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Eli Lilly Pain Reliever Product Portfolio
6.6.5 Eli Lilly Recent Developments/Updates
6.7 AstraZeneca
6.7.1 AstraZeneca Company Information
6.7.2 AstraZeneca Description and Business Overview
6.7.3 AstraZeneca Pain Reliever Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 AstraZeneca Pain Reliever Product Portfolio
6.7.5 AstraZeneca Recent Developments/Updates
6.8 Endo
6.8.1 Endo Company Information
6.8.2 Endo Description and Business Overview
6.8.3 Endo Pain Reliever Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Endo Pain Reliever Product Portfolio
6.8.5 Endo Recent Developments/Updates
6.9 Merck
6.9.1 Merck Company Information
6.9.2 Merck Description and Business Overview
6.9.3 Merck Pain Reliever Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Merck Pain Reliever Product Portfolio
6.9.5 Merck Recent Developments/Updates
6.10 Depomed
6.10.1 Depomed Company Information
6.10.2 Depomed Description and Business Overview
6.10.3 Depomed Pain Reliever Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Depomed Pain Reliever Product Portfolio
6.10.5 Depomed Recent Developments/Updates
6.11 Yunnan Baiyao
6.11.1 Yunnan Baiyao Company Information
6.11.2 Yunnan Baiyao Description and Business Overview
6.11.3 Yunnan Baiyao Pain Reliever Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Yunnan Baiyao Pain Reliever Product Portfolio
6.11.5 Yunnan Baiyao Recent Developments/Updates
6.12 Teva
6.12.1 Teva Company Information
6.12.2 Teva Description and Business Overview
6.12.3 Teva Pain Reliever Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Teva Pain Reliever Product Portfolio
6.12.5 Teva Recent Developments/Updates
6.13 J&J
6.13.1 J&J Company Information
6.13.2 J&J Description and Business Overview
6.13.3 J&J Pain Reliever Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 J&J Pain Reliever Product Portfolio
6.13.5 J&J Recent Developments/Updates
6.14 Allergan
6.14.1 Allergan Company Information
6.14.2 Allergan Description and Business Overview
6.14.3 Allergan Pain Reliever Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 Allergan Pain Reliever Product Portfolio
6.14.5 Allergan Recent Developments/Updates
6.15 Purdue
6.15.1 Purdue Company Information
6.15.2 Purdue Description and Business Overview
6.15.3 Purdue Pain Reliever Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 Purdue Pain Reliever Product Portfolio
6.15.5 Purdue Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Pain Reliever Industry Chain Analysis
7.2 Pain Reliever Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Pain Reliever Production Mode & Process Analysis
7.4 Pain Reliever Sales and Marketing
7.4.1 Pain Reliever Sales Channels
7.4.2 Pain Reliever Distributors
7.5 Pain Reliever Customer Analysis
8 Pain Reliever Market Dynamics
8.1 Pain Reliever Industry Trends
8.2 Pain Reliever Market Drivers
8.3 Pain Reliever Market Challenges
8.4 Pain Reliever Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Pain Reliever Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Pain Reliever Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Pain Reliever Market Competitive Situation by Manufacturers in 2025
Table 4. Global Pain Reliever Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Pain Reliever Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Pain Reliever Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Pain Reliever Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Pain Reliever Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Pain Reliever, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Pain Reliever, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Pain Reliever, Product Types and Applications
Table 12. Global Key Manufacturers of Pain Reliever, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Pain Reliever Companies by Tier (Tier 1, Tier 2, Tier 3), based on Pain Reliever Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Pain Reliever Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Pain Reliever Sales by Region (K Units), 2021–2026
Table 18. Global Pain Reliever Sales Market Share by Region (2021–2026)
Table 19. Global Pain Reliever Sales by Region (K Units), 2027–2032
Table 20. Global Pain Reliever Sales Market Share by Region (2027–2032)
Table 21. Global Pain Reliever Revenue by Region (US$ Million), 2021–2026
Table 22. Global Pain Reliever Revenue Market Share by Region (2021–2026)
Table 23. Global Pain Reliever Revenue by Region (US$ Million), 2027–2032
Table 24. Global Pain Reliever Revenue Market Share by Region (2027–2032)
Table 25. North America Pain Reliever Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Pain Reliever Sales by Country (K Units), 2021–2026
Table 27. North America Pain Reliever Sales by Country (K Units), 2027–2032
Table 28. North America Pain Reliever Revenue by Country (US$ Million), 2021–2026
Table 29. North America Pain Reliever Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Pain Reliever Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Pain Reliever Sales by Country (K Units), 2021–2026
Table 32. Europe Pain Reliever Sales by Country (K Units), 2027–2032
Table 33. Europe Pain Reliever Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Pain Reliever Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Pain Reliever Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Pain Reliever Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Pain Reliever Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Pain Reliever Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Pain Reliever Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Pain Reliever Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Pain Reliever Sales by Country (K Units), 2021–2026
Table 42. Latin America Pain Reliever Sales by Country (K Units), 2027–2032
Table 43. Latin America Pain Reliever Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Pain Reliever Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Pain Reliever Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Pain Reliever Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Pain Reliever Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Pain Reliever Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Pain Reliever Revenue by Country (US$ Million), 2027–2032
Table 50. Global Pain Reliever Sales (K Units) by Type (2021–2026)
Table 51. Global Pain Reliever Sales (K Units) by Type (2027–2032)
Table 52. Global Pain Reliever Sales Market Share by Type (2021–2026)
Table 53. Global Pain Reliever Sales Market Share by Type (2027–2032)
Table 54. Global Pain Reliever Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Pain Reliever Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Pain Reliever Revenue Market Share by Type (2021–2026)
Table 57. Global Pain Reliever Revenue Market Share by Type (2027–2032)
Table 58. Global Pain Reliever Price (US$/Unit) by Type (2021–2026)
Table 59. Global Pain Reliever Price (US$/Unit) by Type (2027–2032)
Table 60. Global Pain Reliever Sales (K Units) by Application (2021–2026)
Table 61. Global Pain Reliever Sales (K Units) by Application (2027–2032)
Table 62. Global Pain Reliever Sales Market Share by Application (2021–2026)
Table 63. Global Pain Reliever Sales Market Share by Application (2027–2032)
Table 64. Global Pain Reliever Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Pain Reliever Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Pain Reliever Revenue Market Share by Application (2021–2026)
Table 67. Global Pain Reliever Revenue Market Share by Application (2027–2032)
Table 68. Global Pain Reliever Price (US$/Unit) by Application (2021–2026)
Table 69. Global Pain Reliever Price (US$/Unit) by Application (2027–2032)
Table 70. Pfizer Company Information
Table 71. Pfizer Description and Business Overview
Table 72. Pfizer Pain Reliever Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Pfizer Pain Reliever Product
Table 74. Pfizer Recent Developments/Updates
Table 75. GSK Company Information
Table 76. GSK Description and Business Overview
Table 77. GSK Pain Reliever Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. GSK Pain Reliever Product
Table 79. GSK Recent Developments/Updates
Table 80. Grunenthal Company Information
Table 81. Grunenthal Description and Business Overview
Table 82. Grunenthal Pain Reliever Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Grunenthal Pain Reliever Product
Table 84. Grunenthal Recent Developments/Updates
Table 85. Bayer Company Information
Table 86. Bayer Description and Business Overview
Table 87. Bayer Pain Reliever Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Bayer Pain Reliever Product
Table 89. Bayer Recent Developments/Updates
Table 90. Sanofi Company Information
Table 91. Sanofi Description and Business Overview
Table 92. Sanofi Pain Reliever Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Sanofi Pain Reliever Product
Table 94. Sanofi Recent Developments/Updates
Table 95. Eli Lilly Company Information
Table 96. Eli Lilly Description and Business Overview
Table 97. Eli Lilly Pain Reliever Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Eli Lilly Pain Reliever Product
Table 99. Eli Lilly Recent Developments/Updates
Table 100. AstraZeneca Company Information
Table 101. AstraZeneca Description and Business Overview
Table 102. AstraZeneca Pain Reliever Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. AstraZeneca Pain Reliever Product
Table 104. AstraZeneca Recent Developments/Updates
Table 105. Endo Company Information
Table 106. Endo Description and Business Overview
Table 107. Endo Pain Reliever Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. Endo Pain Reliever Product
Table 109. Endo Recent Developments/Updates
Table 110. Merck Company Information
Table 111. Merck Description and Business Overview
Table 112. Merck Pain Reliever Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. Merck Pain Reliever Product
Table 114. Merck Recent Developments/Updates
Table 115. Depomed Company Information
Table 116. Depomed Description and Business Overview
Table 117. Depomed Pain Reliever Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 118. Depomed Pain Reliever Product
Table 119. Depomed Recent Developments/Updates
Table 120. Yunnan Baiyao Company Information
Table 121. Yunnan Baiyao Description and Business Overview
Table 122. Yunnan Baiyao Pain Reliever Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 123. Yunnan Baiyao Pain Reliever Product
Table 124. Yunnan Baiyao Recent Developments/Updates
Table 125. Teva Company Information
Table 126. Teva Description and Business Overview
Table 127. Teva Pain Reliever Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 128. Teva Pain Reliever Product
Table 129. Teva Recent Developments/Updates
Table 130. J&J Company Information
Table 131. J&J Description and Business Overview
Table 132. J&J Pain Reliever Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 133. J&J Pain Reliever Product
Table 134. J&J Recent Developments/Updates
Table 135. Allergan Company Information
Table 136. Allergan Description and Business Overview
Table 137. Allergan Pain Reliever Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 138. Allergan Pain Reliever Product
Table 139. Allergan Recent Developments/Updates
Table 140. Purdue Company Information
Table 141. Purdue Description and Business Overview
Table 142. Purdue Pain Reliever Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 143. Purdue Pain Reliever Product
Table 144. Purdue Recent Developments/Updates
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. Pain Reliever Distributors List
Table 148. Pain Reliever Customers List
Table 149. Pain Reliever Market Trends
Table 150. Pain Reliever Market Drivers
Table 151. Pain Reliever Market Challenges
Table 152. Pain Reliever Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
Table 156. Authors List of This Report
List of Figures
Figure 1. Product Picture of Pain Reliever
Figure 2. Global Pain Reliever Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Pain Reliever Market Share by Type: 2025 & 2032
Figure 4. Generic Opioids Product Picture
Figure 5. Branded Opioids Product Picture
Figure 6. NSAIDs Product Picture
Figure 7. Others Product Picture
Figure 8. Global Pain Reliever Market Value by Application (US$ Million), 2021–2032
Figure 9. Global Pain Reliever Market Share by Application: 2025 & 2032
Figure 10. Hospitals
Figure 11. Clinics
Figure 12. Drugstores
Figure 13. Global Pain Reliever Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 14. Global Pain Reliever Market Size (US$ Million), 2021–2032
Figure 15. Global Pain Reliever Sales (K Units), 2021–2032
Figure 16. Global Pain Reliever Average Price (US$/Unit), 2021–2032
Figure 17. Pain Reliever Report Years Considered
Figure 18. Pain Reliever Sales Share by Manufacturers in 2025
Figure 19. Global Pain Reliever Revenue Share by Manufacturers in 2025
Figure 20. Top 5 and Top 10 Global Pain Reliever Players: Market Share by Revenue in Pain Reliever in 2025
Figure 21. Pain Reliever Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 22. Global Pain Reliever Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 23. North America Pain Reliever Sales Market Share by Country (2021–2032)
Figure 24. North America Pain Reliever Revenue Market Share by Country (2021–2032)
Figure 25. United States Pain Reliever Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Canada Pain Reliever Revenue Growth Rate (US$ Million), 2021–2032
Figure 27. Europe Pain Reliever Sales Market Share by Country (2021–2032)
Figure 28. Europe Pain Reliever Revenue Market Share by Country (2021–2032)
Figure 29. Germany Pain Reliever Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. France Pain Reliever Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. U.K. Pain Reliever Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Italy Pain Reliever Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Russia Pain Reliever Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. Asia Pacific Pain Reliever Sales Market Share by Region (2021–2032)
Figure 35. Asia Pacific Pain Reliever Revenue Market Share by Region (2021–2032)
Figure 36. China Pain Reliever Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. Japan Pain Reliever Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. South Korea Pain Reliever Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. India Pain Reliever Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Australia Pain Reliever Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. China Taiwan Pain Reliever Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Indonesia Pain Reliever Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Thailand Pain Reliever Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Malaysia Pain Reliever Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Latin America Pain Reliever Sales Market Share by Country (2021–2032)
Figure 46. Latin America Pain Reliever Revenue Market Share by Country (2021–2032)
Figure 47. Mexico Pain Reliever Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Brazil Pain Reliever Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Argentina Pain Reliever Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Middle East and Africa Pain Reliever Sales Market Share by Country (2021–2032)
Figure 51. Middle East and Africa Pain Reliever Revenue Market Share by Country (2021–2032)
Figure 52. Turkey Pain Reliever Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Saudi Arabia Pain Reliever Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. UAE Pain Reliever Revenue Growth Rate (US$ Million), 2021–2032
Figure 55. Global Sales Market Share of Pain Reliever by Type (2021–2032)
Figure 56. Global Revenue Market Share of Pain Reliever by Type (2021–2032)
Figure 57. Global Pain Reliever Price (US$/Unit) by Type (2021–2032)
Figure 58. Global Sales Market Share of Pain Reliever by Application (2021–2032)
Figure 59. Global Revenue Market Share of Pain Reliever by Application (2021–2032)
Figure 60. Global Pain Reliever Price (US$/Unit) by Application (2021–2032)
Figure 61. Pain Reliever Value Chain
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Table 1. Global Pain Reliever Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Pain Reliever Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Pain Reliever Market Competitive Situation by Manufacturers in 2025
Table 4. Global Pain Reliever Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Pain Reliever Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Pain Reliever Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Pain Reliever Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Pain Reliever Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Pain Reliever, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Pain Reliever, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Pain Reliever, Product Types and Applications
Table 12. Global Key Manufacturers of Pain Reliever, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Pain Reliever Companies by Tier (Tier 1, Tier 2, Tier 3), based on Pain Reliever Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Pain Reliever Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Pain Reliever Sales by Region (K Units), 2021–2026
Table 18. Global Pain Reliever Sales Market Share by Region (2021–2026)
Table 19. Global Pain Reliever Sales by Region (K Units), 2027–2032
Table 20. Global Pain Reliever Sales Market Share by Region (2027–2032)
Table 21. Global Pain Reliever Revenue by Region (US$ Million), 2021–2026
Table 22. Global Pain Reliever Revenue Market Share by Region (2021–2026)
Table 23. Global Pain Reliever Revenue by Region (US$ Million), 2027–2032
Table 24. Global Pain Reliever Revenue Market Share by Region (2027–2032)
Table 25. North America Pain Reliever Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Pain Reliever Sales by Country (K Units), 2021–2026
Table 27. North America Pain Reliever Sales by Country (K Units), 2027–2032
Table 28. North America Pain Reliever Revenue by Country (US$ Million), 2021–2026
Table 29. North America Pain Reliever Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Pain Reliever Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Pain Reliever Sales by Country (K Units), 2021–2026
Table 32. Europe Pain Reliever Sales by Country (K Units), 2027–2032
Table 33. Europe Pain Reliever Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Pain Reliever Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Pain Reliever Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Pain Reliever Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Pain Reliever Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Pain Reliever Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Pain Reliever Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Pain Reliever Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Pain Reliever Sales by Country (K Units), 2021–2026
Table 42. Latin America Pain Reliever Sales by Country (K Units), 2027–2032
Table 43. Latin America Pain Reliever Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Pain Reliever Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Pain Reliever Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Pain Reliever Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Pain Reliever Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Pain Reliever Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Pain Reliever Revenue by Country (US$ Million), 2027–2032
Table 50. Global Pain Reliever Sales (K Units) by Type (2021–2026)
Table 51. Global Pain Reliever Sales (K Units) by Type (2027–2032)
Table 52. Global Pain Reliever Sales Market Share by Type (2021–2026)
Table 53. Global Pain Reliever Sales Market Share by Type (2027–2032)
Table 54. Global Pain Reliever Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Pain Reliever Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Pain Reliever Revenue Market Share by Type (2021–2026)
Table 57. Global Pain Reliever Revenue Market Share by Type (2027–2032)
Table 58. Global Pain Reliever Price (US$/Unit) by Type (2021–2026)
Table 59. Global Pain Reliever Price (US$/Unit) by Type (2027–2032)
Table 60. Global Pain Reliever Sales (K Units) by Application (2021–2026)
Table 61. Global Pain Reliever Sales (K Units) by Application (2027–2032)
Table 62. Global Pain Reliever Sales Market Share by Application (2021–2026)
Table 63. Global Pain Reliever Sales Market Share by Application (2027–2032)
Table 64. Global Pain Reliever Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Pain Reliever Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Pain Reliever Revenue Market Share by Application (2021–2026)
Table 67. Global Pain Reliever Revenue Market Share by Application (2027–2032)
Table 68. Global Pain Reliever Price (US$/Unit) by Application (2021–2026)
Table 69. Global Pain Reliever Price (US$/Unit) by Application (2027–2032)
Table 70. Pfizer Company Information
Table 71. Pfizer Description and Business Overview
Table 72. Pfizer Pain Reliever Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Pfizer Pain Reliever Product
Table 74. Pfizer Recent Developments/Updates
Table 75. GSK Company Information
Table 76. GSK Description and Business Overview
Table 77. GSK Pain Reliever Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. GSK Pain Reliever Product
Table 79. GSK Recent Developments/Updates
Table 80. Grunenthal Company Information
Table 81. Grunenthal Description and Business Overview
Table 82. Grunenthal Pain Reliever Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Grunenthal Pain Reliever Product
Table 84. Grunenthal Recent Developments/Updates
Table 85. Bayer Company Information
Table 86. Bayer Description and Business Overview
Table 87. Bayer Pain Reliever Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Bayer Pain Reliever Product
Table 89. Bayer Recent Developments/Updates
Table 90. Sanofi Company Information
Table 91. Sanofi Description and Business Overview
Table 92. Sanofi Pain Reliever Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Sanofi Pain Reliever Product
Table 94. Sanofi Recent Developments/Updates
Table 95. Eli Lilly Company Information
Table 96. Eli Lilly Description and Business Overview
Table 97. Eli Lilly Pain Reliever Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Eli Lilly Pain Reliever Product
Table 99. Eli Lilly Recent Developments/Updates
Table 100. AstraZeneca Company Information
Table 101. AstraZeneca Description and Business Overview
Table 102. AstraZeneca Pain Reliever Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. AstraZeneca Pain Reliever Product
Table 104. AstraZeneca Recent Developments/Updates
Table 105. Endo Company Information
Table 106. Endo Description and Business Overview
Table 107. Endo Pain Reliever Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. Endo Pain Reliever Product
Table 109. Endo Recent Developments/Updates
Table 110. Merck Company Information
Table 111. Merck Description and Business Overview
Table 112. Merck Pain Reliever Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. Merck Pain Reliever Product
Table 114. Merck Recent Developments/Updates
Table 115. Depomed Company Information
Table 116. Depomed Description and Business Overview
Table 117. Depomed Pain Reliever Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 118. Depomed Pain Reliever Product
Table 119. Depomed Recent Developments/Updates
Table 120. Yunnan Baiyao Company Information
Table 121. Yunnan Baiyao Description and Business Overview
Table 122. Yunnan Baiyao Pain Reliever Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 123. Yunnan Baiyao Pain Reliever Product
Table 124. Yunnan Baiyao Recent Developments/Updates
Table 125. Teva Company Information
Table 126. Teva Description and Business Overview
Table 127. Teva Pain Reliever Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 128. Teva Pain Reliever Product
Table 129. Teva Recent Developments/Updates
Table 130. J&J Company Information
Table 131. J&J Description and Business Overview
Table 132. J&J Pain Reliever Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 133. J&J Pain Reliever Product
Table 134. J&J Recent Developments/Updates
Table 135. Allergan Company Information
Table 136. Allergan Description and Business Overview
Table 137. Allergan Pain Reliever Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 138. Allergan Pain Reliever Product
Table 139. Allergan Recent Developments/Updates
Table 140. Purdue Company Information
Table 141. Purdue Description and Business Overview
Table 142. Purdue Pain Reliever Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 143. Purdue Pain Reliever Product
Table 144. Purdue Recent Developments/Updates
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. Pain Reliever Distributors List
Table 148. Pain Reliever Customers List
Table 149. Pain Reliever Market Trends
Table 150. Pain Reliever Market Drivers
Table 151. Pain Reliever Market Challenges
Table 152. Pain Reliever Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
Table 156. Authors List of This Report
List of Figures
Figure 1. Product Picture of Pain Reliever
Figure 2. Global Pain Reliever Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Pain Reliever Market Share by Type: 2025 & 2032
Figure 4. Generic Opioids Product Picture
Figure 5. Branded Opioids Product Picture
Figure 6. NSAIDs Product Picture
Figure 7. Others Product Picture
Figure 8. Global Pain Reliever Market Value by Application (US$ Million), 2021–2032
Figure 9. Global Pain Reliever Market Share by Application: 2025 & 2032
Figure 10. Hospitals
Figure 11. Clinics
Figure 12. Drugstores
Figure 13. Global Pain Reliever Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 14. Global Pain Reliever Market Size (US$ Million), 2021–2032
Figure 15. Global Pain Reliever Sales (K Units), 2021–2032
Figure 16. Global Pain Reliever Average Price (US$/Unit), 2021–2032
Figure 17. Pain Reliever Report Years Considered
Figure 18. Pain Reliever Sales Share by Manufacturers in 2025
Figure 19. Global Pain Reliever Revenue Share by Manufacturers in 2025
Figure 20. Top 5 and Top 10 Global Pain Reliever Players: Market Share by Revenue in Pain Reliever in 2025
Figure 21. Pain Reliever Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 22. Global Pain Reliever Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 23. North America Pain Reliever Sales Market Share by Country (2021–2032)
Figure 24. North America Pain Reliever Revenue Market Share by Country (2021–2032)
Figure 25. United States Pain Reliever Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Canada Pain Reliever Revenue Growth Rate (US$ Million), 2021–2032
Figure 27. Europe Pain Reliever Sales Market Share by Country (2021–2032)
Figure 28. Europe Pain Reliever Revenue Market Share by Country (2021–2032)
Figure 29. Germany Pain Reliever Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. France Pain Reliever Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. U.K. Pain Reliever Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Italy Pain Reliever Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Russia Pain Reliever Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. Asia Pacific Pain Reliever Sales Market Share by Region (2021–2032)
Figure 35. Asia Pacific Pain Reliever Revenue Market Share by Region (2021–2032)
Figure 36. China Pain Reliever Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. Japan Pain Reliever Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. South Korea Pain Reliever Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. India Pain Reliever Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Australia Pain Reliever Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. China Taiwan Pain Reliever Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Indonesia Pain Reliever Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Thailand Pain Reliever Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Malaysia Pain Reliever Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Latin America Pain Reliever Sales Market Share by Country (2021–2032)
Figure 46. Latin America Pain Reliever Revenue Market Share by Country (2021–2032)
Figure 47. Mexico Pain Reliever Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Brazil Pain Reliever Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Argentina Pain Reliever Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Middle East and Africa Pain Reliever Sales Market Share by Country (2021–2032)
Figure 51. Middle East and Africa Pain Reliever Revenue Market Share by Country (2021–2032)
Figure 52. Turkey Pain Reliever Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Saudi Arabia Pain Reliever Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. UAE Pain Reliever Revenue Growth Rate (US$ Million), 2021–2032
Figure 55. Global Sales Market Share of Pain Reliever by Type (2021–2032)
Figure 56. Global Revenue Market Share of Pain Reliever by Type (2021–2032)
Figure 57. Global Pain Reliever Price (US$/Unit) by Type (2021–2032)
Figure 58. Global Sales Market Share of Pain Reliever by Application (2021–2032)
Figure 59. Global Revenue Market Share of Pain Reliever by Application (2021–2032)
Figure 60. Global Pain Reliever Price (US$/Unit) by Application (2021–2032)
Figure 61. Pain Reliever Value Chain
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Physical Graphing Calculators Market Research Report 2026
Nov 14, 26
Global Graphics Calculators Market Research Report 2026
Nov 14, 26
Global Internet and Wi-fi Connected Smart Dishwashers Market Research Report 2026
Nov 14, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232